Cargando…
Involvement of epigenetic modification of TERT promoter in response to all-trans retinoic acid in ovarian cancer cell lines
BACKGROUND: All-trans retinoic acid (ATRA) is currently being used to treat hematological malignancies, given the ability to inhibit cell proliferation. This effect seems to be related to epigenetic changes of the TERT (Telomerase Reverse Transcriptase) promoter. When hypomethylated, ATRA-inducible...
Autores principales: | Losi, Lorena, Lauriola, Angela, Tazzioli, Erica, Gozzi, Gaia, Scurani, Letizia, D’Arca, Domenico, Benhattar, Jean |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617683/ https://www.ncbi.nlm.nih.gov/pubmed/31291979 http://dx.doi.org/10.1186/s13048-019-0536-y |
Ejemplares similares
-
A Peptidic Thymidylate-Synthase Inhibitor Loaded on Pegylated Liposomes Enhances the Antitumour Effect of Chemotherapy Drugs in Human Ovarian Cancer Cells
por: Marverti, Gaetano, et al.
Publicado: (2020) -
The 1,10-Phenanthroline Ligand Enhances the Antiproliferative Activity of DNA-Intercalating Thiourea-Pd(II) and -Pt(II) Complexes Against Cisplatin-Sensitive and -Resistant Human Ovarian Cancer Cell Lines
por: Marverti, Gaetano, et al.
Publicado: (2019) -
Identification of a Quinone Derivative as a YAP/TEAD Activity Modulator from a Repurposing Library
por: Lauriola, Angela, et al.
Publicado: (2022) -
High Expression of hTERT and Stemness Genes in BORIS/CTCFL Positive Cells Isolated from Embryonic Cancer Cells
por: Alberti, Loredana, et al.
Publicado: (2014) -
Structural Bases for the Synergistic Inhibition of Human Thymidylate Synthase and Ovarian Cancer Cell Growth by Drug Combinations
por: Pozzi, Cecilia, et al.
Publicado: (2021)